Pharma’s Productivity Problem: Finding More Blockbuster Drugs
Xconomy
AUGUST 16, 2016
An obvious place to look for help is the venture community—Bruce Booth of Atlas Ventures pointed out in a recent blog that venture capital is doing well, and is positioned to do even better in the future. Yet despite relative plenty in the bio-venture community, pharma suffers from a shortage of drug candidates.
40 
Let's personalize your content